Feifei Luo
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 27
- Immune Cell Function and Interaction 12
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 9
- Immune Response and Inflammation 7
- Oncology 18
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Yiwei Chu (24 shared papers)Jiao Yang (10 shared papers)Yuedi Wang (9 shared papers)Jiawen Qian (10 shared papers)Ronghua Liu (4 shared papers)Yuting Deng (7 shared papers)Luman Wang (5 shared papers)Chujun Julia Zhao (2 shared papers)
- Journals
- Frontiers in Immunology (5 papers)Cancer Immunology Immunotherapy (3 papers)Signal Transduction and Targeted Therapy (2 papers)Clinical and Translational Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Feifei Luo
63 papers receiving 2.3k citations
Feifei Luo's Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 889
- Oncology 755
- Cancer Research 275
- Genetics 162
- Neurology 98
Countries citing papers authored by Feifei Luo
This map shows the geographic impact of Feifei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Luo more than expected).
Fields of papers citing papers by Feifei Luo
This network shows the impact of papers produced by Feifei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Luo. The network helps show where Feifei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 219 | |
| 2 | 2020 | 147 | |
| 3 | 2011 | 107 | |
| 4 | 2017 | 94 | |
| 5 | 2018 | 93 | |
| 6 | 2018 | 91 | |
| 7 | 2022 | 88 | |
| 8 | 2018 | 84 | |
| 9 | 2021 | 75 | |
| 10 | 2002 | 72 | |
| 11 | 2017 | 71 | |
| 12 | 2019 | 71 | |
| 13 | 2011 | 60 | |
| 14 | 1996 | 59 | |
| 15 | 2018 | 55 | |
| 16 | 2015 | 52 | |
| 17 | 2009 | 51 | |
| 18 | Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy Hit paper breakdown → | 2025 | 50 |
| 19 | 2019 | 46 | |
| 20 | 1993 | 45 |
About Feifei Luo
Feifei Luo is a scholar working on Immunology, Oncology, Cancer Research, Genetics and Neurology, having authored 63 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (10 papers), Immune cells in cancer (9 papers), Immune Response and Inflammation (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Virus-based gene therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Immunology (889 citations), Oncology (755 citations), Cancer Research (275 citations), Genetics (162 citations) and Neurology (98 citations). Feifei Luo has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Yiwei Chu, Jiao Yang, Yuedi Wang, Jiawen Qian, Ronghua Liu, Yuting Deng, Luman Wang, Chujun Julia Zhao, Jie Liu and Yufei Zhang. Their work appears in journals such as Frontiers in Immunology, Cancer Immunology Immunotherapy, Signal Transduction and Targeted Therapy, Clinical and Translational Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.